Member Info for sir_digby

ONS and ZOE, ZOE is volunteer driven and makes pretty accurate real time predictions. ONS is usually a week or two lagging. ZOE currently showing cases on the rise again.

I see they're just going with the Mullis and Dyer being greedy and profiteering line these days, omitting the fraud accusations they made earlier in the year. It's a funny old world, to quote the Eye themselves.

https://t.co/vDBhEfwDOA

The rest of the sector isn't up, ekf up 3% on tiny volume. NCYT volume roughly double in France, closed up 6%. The likes of Twitter very quiet.

Yes, there's a lot of focus on China. Caught between the devil and the deep blue sea. The people are understandably desperate to lift restrictions but any relaxation will result in a massive omicron wave with huge personal and economic consequences, not just for them.

It's an awful regime and it's Hobson's choice now for them.

Wait until those fake deaths start piling up in China and the global supply chain suffers a shock nobody is prepared for.

There's already a global shortage of antibiotics and other medicines manufactured there, wait until China tells the West that they've embargoed the export of all these products to fulfill their own dire needs. Hong Kong got hammered earlier in the year with better vaccination rates, better vaccines and better healthcare provision. 1.2 billion naive individuals, what could possibly go wrong.

The difference between NCYT and abdx is NCYT theoretically have no shortage of (within limits) time and money to thrash out this dispute with the DHSC, the DHSCs money to be precise. That wouldn't suit most shareholders who'd prefer this to be done and dusted, me included but it's reality. Financially abdx were on the ropes.

Good to see a MSM article at least attempting to take a critical look at the government's behavior towards UK diagnostics.

12 days later and Allmond is still listed as CEO on the company site. Sums up this shambles.

The pestfix settlement represents 20% of the £350m they received. If gowns are the wrong size it's not subjective and they've still came out £280m ahead, the accuracy of our assays is. All the company has to do is show that the sample collection methods were flawed or there were shortcomings in the processing of the tests. They've already accredited every assay we've supplied under contract to the DHSC, using their own very rigorous process.

If biosynex are still holding their 4.5% they are sitting on a titanic loss, they should up their holding to 5%, request an egm and remove the chairman (for starters). Then get to work replacing the lapdog 'interim' CEO and move on from this shambles of a BOD. As CFO he has overseen a 95% fall in the sp, sacking performance in any other company, he's been sh@t along with every other clown on this board.

They have authority to buy back 10% of shares, even assuming a 50% uplift as a result it would cost no more than £6m, it's not as if they spending the money on acquiring assets. The excuses wore thin long ago.

Fiduciary duty my @rse.

@crl123, we are governed by French governance rules, hence why there are quorum thresholds required for agms. The numbers required to call an egm will be dictated by french rules where we are primarily listed.

And the property and it/is and the stock on hand, the list of things valued at less than zero goes on and on.

Under French rules don't you only need 5% to call an egm?

Suspected UK case of ebola.

https://t.co/Ze78nKiF2z

And launched 40 CE IVD assays on Twitter. It's deliberate, nobody could be this inept.

Looks like China is losing its grip on its zero covid policy, record numbers daily now. They're seeing early signs of exponential growth in Beijing, small numbers but doubling daily.

Setting aside the obvious health implications for its 1 billion naive citizens who are protected by what's widely regarded as a sh@t vaccine. The damage to the global supply chain could be devastating.

The dispute hasn't even gone to court. He's been sacked, that's just flowery language to save face in the rns.

Wilson, had a feeling it was him when I saw the title before reading it

12 months of delivering SFA I imagine prompted this.

Won't see too many tears amongst shareholders

Is the clonit deal going to cover the discontinued assays, it would make sense in not having duplication. Perhaps clonits assays are cheaper for us to peddle?

It's only November, as they say 'the US sneezes, we catch a cold'.

https://twitter.com/DGBassani/status/1588633481642676224?t=qahJuRCTvDahpPvEOu8VGA&s=19

https://t.co/LzVp4Vkt6c